Triamcinolone
Half-Life (t½) TD: 4h
Formula C21H27FO6
Molecular Weight 394.43 g/mol
Aliases Kenalog Pharmacological Mechanism Mid-potency synthetic glucocorticoid — fluorinated to enhance receptor affinity. Available topical, intra-articular (Kenalog injection), inhaled (nasal), and intra-ocular. Common for joint injections in osteoarthritis flares + dermatologic flares.
Half-Life & Elimination Curve (TD: 4h) 100% 50% 25% 12.5% 0% 0h 0×t½ 4h 1×t½ 8h 2×t½ 12h 3×t½ 16h 4×t½ 20h 5×t½ 0×t½ (0h): 100% remaining 1×t½ (4h): 50% remaining 2×t½ (8h): 25% remaining 3×t½ (12h): 12.5% remaining 4×t½ (16h): 6.3% remaining 5×t½ (20h): 3.1% remaining Elimination (TD) Effect Site (ke0)
0×t½ 0h 100% 1×t½ 4h 50% 2×t½ 8h 25% 3×t½ 12h 12.5% 4×t½ 16h 6.3% 5×t½ 20h 3.1% Dosing Guidelines Transdermal (TD): Typical 0.1 mg (Range: 0.025–0.5 mg)Pharmacokinetic Parameters Effect-Site Equilibration (ke0): 0.1 h⁻¹ (equilibration half-time t½ke0 ≈ 6.93h)Receptor Binding & Occupancy Pathways It Modulates Target Organ Systems Chemical Structure & Identifiers InChIKey: GFNANZIMVAIWHM-OBYCQNJPSA-NSMILES: C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)OReferences Directory Compounds Registry Human Biology Hub